Assessment of fetal inflammatory syndrome by "classical" markers in the management of preterm labor: A possible lesson from metabolomics and system biology

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue SUPPL. 5, 2012, Pages 54-61

  Ferrazzi, Enrico ^a   Muggiasca, Maria Luisa ^a   Fabbri, Elisa ^a   Fontana, Paola ^b   Castoldi, Francesco ^b   Lista, Gianluca ^b   Primerano, Liviana ^a   Livio, Stefania ^a   Di Francesco, Stefania ^a  

^a V BUZZI CHILDREN S HOSPITAL   (Italy)

^b ICP   (Italy)

Author keywords

Amniocentesis; Fetal inflammatory syndrome; Intra amniotic inflammation; Metabolomics; Preterm delivery; Tocolysis

Indexed keywords

ANTIBIOTIC AGENT; ATOSIBAN; BETAMETHASONE; CEFTAZIDIME; CLINDAMYCIN; INDOMETACIN; PROGESTERONE; RITODRINE; UTERUS SPASMOLYTIC AGENT;

ADULT; AMNION FLUID ANALYSIS; ARTICLE; BACTERIUM CULTURE; BRAIN HEMORRHAGE; CHORIOAMNIONITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FETAL INFLAMMATORY SYNDROME; FETUS; FETUS DISEASE; FETUS OUTCOME; HUMAN; LENGTH OF STAY; LEUKOCYTE COUNT; LUNG DYSPLASIA; METABOLOMICS; NEWBORN; NEWBORN ASSESSMENT; NEWBORN INTENSIVE CARE; POSITIVE END EXPIRATORY PRESSURE; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SYSTEMS BIOLOGY; TOCOLYSIS; TREATMENT OUTCOME; UREAPLASMA INFECTION; UTERINE CERVIX CERCLAGE;

AMNIOTIC FLUID; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CHORIOAMNIONITIS; FEMALE; FETAL DISEASES; FETAL MEMBRANES, PREMATURE RUPTURE; GESTATIONAL AGE; HUMANS; INFLAMMATION; INTENSIVE CARE UNITS, NEONATAL; LENGTH OF STAY; LEUKOCYTE COUNT; METABOLOMICS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; TOCOLYTIC AGENTS;

EID: 84867027986     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2012.716984     Document Type: Article

References (32)

1. Tomas W, Speer C P. Chorioamnionitis: important risk factor or innocent bystander for neonatal outcome? Neonatology 2011;99:177-187.
2. Sorokin Y, Romero R, Mele L, Wapner RJ, Iams JD, Dudley DJ, Spong CY, et al. Maternal serum interleukin-6, C-reactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birth <32 weeks and adverse neonatal outcomes. Am J Perinatol 2010;27:631-640.
3. Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, Berry SM. A fetal systemic infammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998;179:186-193.
4. Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, Chaiworapongsa T, et al. The preterm parturition syndrome. BJOG 2006;113 Suppl:317-342.
5. Hutzal CE, Boyle EM, Kenyon SL, Nash J V, Winsor S, Taylor DJ, Kirpalani H. Use of antibiotics for the treatment of preterm parturition and prevention of neonatal morbidity: a metaanalysis. Am J Obstet Gynecol 2008;199:620.e1-620.e8.
6. Faksh A, Wax JR, Lucas FL, Cartin A, Pinette MG. Preterm premature rupture of membranes = 32 weeks' gestation: impact of revised practice guidelines. Am J Obstet Gynecol 2011;205:340.e1-340.e5.
7. Ingemarsson I. Tocolytic therapy and clinical experience. Combination therapy. BJOG 2005;112 Suppl 1:89-93.
8. Lamont RF. Antibiotics used in women at risk of preterm birth. Am J Obstet Gynecol 2008;199:583-584.
9. Gomez R R, Romero R, Nien JK, Medina L, Carstens M, Kim, YM, Espinoza J, et al. Antibiotic administration to patients with preterm premature rupture of membranes does not eradicate intra-amniotic infection. J Matern Fetal Neonatal Med 2007;20:167\173
10. Lee SE, Romero R, Park C W, Jun JK, Yoon BH. The frequency and signifcance of intraamniotic infammation in patients with cervical insufciency. Am J Obstet Gynecol 2008;198:633.e1-633.e8.
11. Gravett MG, Adams KM, Sadowsky DW, Grosvenor AR, Witkin SS, Axthelm MK, Novy MJ. Immunomodulators plus antibiotics delay preterm delivery afer experimental intraamniotic infection in a nonhuman primate model. Am J Obstet Gynecol 2007;197:518.e1-518.e8.
12. Buhimschi IA, Zhao G, Pettker CM, Bahtiyar MO, Magloire LK, Tung S, Fairchild T, Buhimschi CS. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and infammation. Am J Obstet Gynecol 2007;196:181.e1-181.13.
13. Mi Lee S, Romero R, Park J W, Kim SM, Park C W, Korzeniewski SJ, Chaiworapongsa T, Yoon BH. The clinical signifcance of a positive Amnisure test in women with preterm labor and intact membranes. J Matern Fetal Neonatal Med 2012.
14. Pereira L, Reddy A P, Alexander AL, Lu X, Lapidus JA, Gravett MG, Nagalla SR. Insights into the multifactorial nature of preterm birth: proteomic profling of the maternal serum glycoproteome and maternal serum peptidome among women in preterm labor. Am J Obstet Gynecol 2010;202:555.e1-555.10.
15. Gravett MG, Novy MJ, Rosenfeld RG, Reddy A P, Jacob T, Turner M, McCormack A, et al. Diagnosis of intra-amniotic infection by proteomic profling and identifcation of novel biomarkers. JAMA 2004;292:462-469.
16. Buhimschi CS, Weiner CP, Buhimschi IA. Clinical proteomics: a novel diagnostic tool forthe new biology of preterm labor: part I, proteomics tools. Obstet Gynecol Surv 2006;61:481-486.
17. Haddad R, Tromp G, Kuivaniemi H, Chaiworapongsa T, Kim YM, Mazor M, Romero R. Human spontaneous labor without histologic chorioamnionitis is characterized by an acute infammation gene expression signature. Am J Obstet Gynecol 2006;195:394.e1-394.24.
18. Crider KS, Whitehead N, Buus RM. Genetic variation associated with preterm birth: a HuGE review. Genet Med 2005;7:593-604.
19. Macones GA, Parry S, Elkousy M, Clothier B, Ural SH, Strauss JF 3rd. A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth. Am J Obstet Gynecol 2004;190:1504-8; discussion 3A.
20. Hassan SS, Romero R, Haddad R, Hendler I, Khalek N, Tromp G, Diamond M P, et al. The transcriptome of the uterine cervix before and afer spontaneous term parturition. Am J Obstet Gynecol 2006;195: 778-786.
21. Dessì A, Atzori L, Noto A, Visser GH, Gazzolo D, Zanardo V, Barberini L, et al. Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome. J Matern Fetal Neonatal Med 2011;24 Suppl 2:35-39.
22. Gracie S, Pennell C, Ekman-Ordeberg G, Lye S, McManaman J, Williams S, Palmer L, et al.; PREBIC "-Omics" Research Group. An integrated systems biology approach to the study of preterm birth using "-omic" technology-a guideline for research. BMC Pregnancy Childbirth 2011;11:71.
23. Gracie S, Pennell C, Ekman-Ordeberg G, Lye S, McManaman J, Williams S, Palmer L, et al. An integrated systems biology approach to the study of preterm birth using "-omic" technology-a guideline for research. BMC Pregnancy Childbirth 2011;11:71.
24. Romero R, Mazaki-Tovi S, Vaisbuch E, Kusanovic JP, Chaiworapongsa T, Gomez R, Nien JK, et al. Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery. J Matern Fetal Neonatal Med 2010;23:1344-1359.
25. Graca G, Duarte IF, Barros AS, Goodfellow BJ, Diaz SO, Pinto J, Carreira IM, et al. Impact of prenatal disorders on the metabolic profle of second trimester amniotic fuid: a nuclear magnetic resonance metabonomic study. J Proteome Res 2010;9:6016-6024.
26. Romero R, Espinoza J, Gotsch F, Kusanovic JP, Friel LA, Erez O, Mazaki-Tovi S, et al. The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome. BJOG 2006;113 Suppl 3:118-135.
27. Bukowski R, Hankins GD, Saade GR, Anderson GD, Tornton S. Labor-associated gene expression in the human uterine fundus, lower segment, and cervix. PLoS Med 2006;3:e169.
28. May C, Patel S, Kennedy C, Pollina E, Raferty GF, Peacock JL, Greenough A. Prediction of bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 2011;96:F410-F416.
29. Romero R, Velez Edwards DR, Kusanovic J P, Hassan SS, Mazaki-Tovi S, Vaisbuch E, Kim CJ, et al. Identifcation of fetal and maternal single nucleotide polymorphisms in candidate genes that predispose to spontaneous preterm labor with intact membranes. Am J Obstet Gynecol 2010;202:431.e1-431.34.
30. Menon R, Peltier MR, Eckardt J, Fortunato SJ. Diversity in cytokine response to bacteria associated with preterm birth by fetal membranes. Am J Obstet Gynecol 2009;201:306.e1-306.e6.
31. Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL. A review of premature birth and subclinical infection. Am J Obstet Gynecol 1992;166:1515-1528.
32. Maynard A. Evidence-based medicine: an incomplete method for informing treatment choices. Lancet 1997;349:126-128.